Does a popular breast cancer gene test underestimate risk for Black women?

A commonly used 21-gene recurrence score is less accurate for Black women, according to recent research.

September 22, 2023 Check out STAT+

Sponsored By

Chris Hondros/Getty Images Opinion: A popular breast cancer genomic test underestimates risks for Black women A commonly used 21-gene test underestimates the risks of breast cancer recurrence in Black women. That needs to change. By Nathalie McDowell Johnson STAT+ | Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial A drug from AstraZeneca tamped down the progression of breast cancer, after the same drug produced underwhelming results in lung cancer. By Andrew Joseph STAT+ | What the Dana-Farber, Brigham divorce means for patients Dana-Farber's break with Brigham means that unwinding the teams that care for cancer patients will likely be extremely complicated. By Jessica Bartlett — Boston Globe

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser